KLTO - ANEW Medical Net earnings per share (EPS TTM)
The current rolling earnings per share level in historical dynamics on the GURU.Markets chart shows that -0.33 is becoming the new value for this metric. Klotho Neurosciences Inc (KLTO) finances rely on preclinical investments. Growth is driven by AI platforms for protein modeling, while the R&D pipeline focuses on s-Klotho therapy against Alzheimer's disease and ALS to combat neurodegeneration.
Financial and market metric breakdowns for ANEW Medical (KLTO)
- share price and expert price forecast:
- market capitalization statistics:
- business book valuation details:
- debt obligations and liquidity statistics:
Debt to Equity Klotho Neurosciences Inc|KLTO - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital ANEW Medical, Inc.|KLTO - Company Cumulative Debt|Debt to Book Value Klotho Neurosciences Inc|KLTO - Company Long-Term Debts|Company Short-Term Debt Klotho Neurosciences|Quick Liquidity anewmeds.com
- earnings and multiples data:
KLTO - Company Net Income|Expected Profit Klotho Neurosciences Inc|KLTO - Business Payback Period|Forward P/E Multiple ANEW Medical, Inc.|KLTO - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Klotho Neurosciences Inc|KLTO - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Klotho Neurosciences|KLTO - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months anewmeds.com|KLTO - Earnings per share growth this year|Earnings growth forecast for next year Klotho Neurosciences Inc
- revenue and sales proceeds data:
Basic company analysis:anewmeds.com - KLTO
Investors must identify the real drivers of business resilience through profitability analysis. This metric is calculated as the ratio of total net income over the last four quarters to the total number of shares outstanding. The current annual net income per share objectifies market expectations regarding the issuer's efficiency. For Klotho Neurosciences Inc (KLTO), this indicator reflects the financial return from the implementation of ethical neurobiological technologies and the optimization of energy costs in "green" clouds.
Competitors of Klotho Neurosciences Inc (KLTO)
BIIB: Net earnings per share for the last 12 months|neurocrine.com - Earnings per share for the last four quarters|RGC: Net earnings per share (EPS TTM)|Axsome - Earnings per share for the trailing year|Earnings per share for the last twelve months ACADIA Pharmaceuticals Inc|Net earnings per one share for the last twelve months Xenon Corp XENE|Net earnings per share for the last 12 months VKTX (Viking Therapeutics)|SUPN (supernus.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Catalyst Pharmaceuticals, Inc. CPRX|DNLI: Earnings per share for the last 12 months|Harmony Pharma - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Biohaven Corp|AMLX (Amylyx Pharmaceuticals) - Net earnings per share for the last 12 months|trevitherapeutics.com (TRVI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Praxis Precision Medicines, Inc.|AVXL: Earnings per share for the trailing year|Earnings per share for the last twelve months CeriBell Corp (CBLL)|PRTA - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Alector ALEC|Net earnings per share for the last four quarters annexonbio.com (ANNX)|Omeros Corp. - Net earnings per share (EPS TTM)|Neurogene Inc (NGNE) - Net earnings per share for the last 12 months|ACIU: Net earnings per share (EPS TTM)|VYGR - Net earnings per share for the last four quarters|NMRA (Neumora Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months scilexholding.com SCLX|Earnings per share for the last twelve months Tevogen Bio (TVGN)|alphacognition.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) CGTX (Cognition Therapeutics)|IKT - Net earnings per share for the last 12 months|Cassava Sciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Assertio Holdings, Inc.|coyatherapeutics.com (COYA) - Earnings per share for the last twelve months|VTGN - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months OVID|ABOS: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CRVO|Net earnings per share for the last four quarters alteritytherapeutics.com|Earnings per share for the last twelve months Clene CLNN|PEPG: Earnings per share for the last 12 months|Jupiter Neurosciences Inc - Net earnings per share (EPS TTM)|Relmada Corp (RLMD) - Net earnings per share for the last 12 months|Annovis Bio, Inc. (ANVS) - Earnings per share for the last twelve months|Grace Therapeutics (GRCE) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Firefly Neuroscience|Earnings per share for the last twelve months NRSN|Net earnings per share for the last 12 months RVPH (Reviva Pharmaceuticals Holdings)|Earnings per share for the last four quarters MTVA|Earnings per share for the last twelve months NeurAxis, Inc. NRXS|Helius Medical Technologies, Inc. (HSDT) - Net earnings per one share for the last twelve months|PASG - Earnings per share for the last twelve months|NEUP (Neuphoria Therapeutics Inc.) - Earnings per share for the last 12 months|NERV: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Athira Pharma Corp (ATHA)|Net earnings per share for the last 12 months ADXN|Net earnings per share (EPS TTM) Alzamend|Earnings per share for the last twelve months Cyclerion Therapeutics (CYCN)|PTIX (protagenic.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Pasithea Therapeutics Corp. KTTA|Cortigent Inc (CRGT) - Net earnings per one share for the last twelve months|ATXI - Earnings per share for the last twelve months|BCLI - Net earnings per share (EPS TTM)|Cara Therapeutics (CARA) - Earnings per share for the last twelve months|CHRO (Chromocell Therapeutics Corp) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Eliem Therapeutics, Inc.|Net earnings per one share for the last twelve months Intra-Cellular ITCI|Net earnings per share for the last 12 months LBPH (Longboard Pharmaceuticals)|Earnings per share for the last four quarters MRNS|Net earnings per share (EPS TTM) NKGN (NKGen Biotech)|Earnings per share for the trailing year NRBO|SAGE - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Synaptogenix, Inc|TRVN (Trevena, Inc.) - Net earnings per share for the last 12 months|Vigil Neuroscience, Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Anew Medical|Earnings per share for the last 12 months CERE (Cerevel Therapeutics Inc)
